Our experienced scientists guide your project setup and execution – as an equal partner for your success.
Better data today.
Better drugs tomorrow.
Arctoris® is your partner from idea to IND
Power your drug discovery with faster, simpler, more reliable data you can trust, generated on Ulysses®, our fully automated R&D platform based in Oxford, UK.
The future of drug discovery is data-driven
Data is the lifeblood of research, and better data leads to better decisions.
We combine robotics, AI, and blockchain to generate robust, reliable, and reproducible data. Partnering with us enables you to make the right decisions
at the right time, and move your programs towards the clinic faster.
Arctoris is revolutionizing the R&D process
We’re a wet lab, but automated
Our robotics generate data 24×7, reducing cycle times and accelerating your research.
Our secure online portal provides real-time data access to your team from anywhere in the world.
Who we partner with
We work with our partners in biotech companies, pharmaceutical corporations, and AI drug discovery across the world to accelerate programs for more efficient drug discovery.
What our partners are saying
“Having visited their robotic lab in Oxford, I know that this is the future of drug discovery. In addition to their remarkable facility, I continue to be impressed by the depth of scientific expertise of the Arctoris team.”
"We have been working with Arctoris on several projects, and they are our go-to solution for new work coming up. The data quality they provide us with using their automated system is fantastic."
“Arctoris’ automated lab and scientific expertise led us to validate our AI-derived drug targets in robust industry-standard assays in an extremely time-efficient manner. Our partnership with Arctoris was fuelled by in-depth scientific discussions, and led to highly significant results.”
“The automated assay developed by Arctoris is sensitive enough to distinguish antibodies at 1nM potency - this makes a huge difference to our company, and will be extremely helpful for anyone involved with antibody research.”
What we’ve been up to
Cyclica and Arctoris to expand partnership to advance drug discovery programs for Alzheimer's disease
Read moreIBM Research and Arctoris accelerate closed loop drug discovery with AI and Cloud
Read moreWhy Should You Automate Your Experiments?
Read moreArctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer
Read moreRole of Pharma Companies in the AI-enabled Drug Discovery Landscape
Read moreDriving the evolution of AI-enabled drug discovery - a global perspective
Read moreArctoris Celebrates 5th Anniversary and Launches Its Expanded Robotic Platform Ulysses
Read moreCelebrating Five Years of Arctoris
Read more5 Myths About Laboratory Automation
Read moreYoung Scholars at a Young Company: Meet our Interns
Read moreBiology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow
Read moreFrom Eroom’s Law to Moore’s Law: Drug Discovery in the 21st Century
Read moreShould I Automate My Cellular Assay?
Read moreChoose the future of drug discovery
Accelerate your programs and start working with higher quality data today.The latest in AI drug discovery
To keep up with the latest news and important developments in AI drug discovery, subscribe here to receive the quarterly Arctoris Report prepared by our experts.